IMpact of Perineural Hydrodissection Over Alternative Therapies in Patients With Carpal Tunnel Syndrome (IMPACTS)
IMpact of Perineural Hydrodissection Over Alternative Therapies in Patients With Carpal Tunnel Syndrome (IMPACTS): A Single-Centre, Randomized Trial Comparing Perineural Hydrodissection of the Median Nerve Versus Steroid Injection in Patients With Carpal Tunnel Syndrome
Sponsor: Leslie Witton
This EARLY_PHASE1 trial investigates Carpal Tunnel Syndrome and is currently ongoing. Leslie Witton leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown EARLY_PHASE1
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status EARLY_PHASE1
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting EARLY_PHASE1
-
Sep 2019 — Jan 2021 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Nov 2018 — Sep 2019 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Sep 2018 — Nov 2018 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Leslie Witton
For direct contact, visit the study record on ClinicalTrials.gov .